HT Family Office

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 1, 2018	OncoResponse	$40.0M Series B	John McKearn	125 Ventures, Canaan Partners, Commerce Ventures, GE Ventures, Thompson Hutton (Thompson Hutton), Alexandria Venture Investments, ARCH Venture Partners, Canaan Partners, Helsinn Investment Fund, Qatar Investment Authority, Redmile Group, William Marsh Rice University
Mar 9, 2017	OncoResponse	$22.5M Series A	姒亭佑 Alvin Syh	—

Total Raised

N/A

Valuation

N/A